£3 million funding to support the development of new antimicrobials for cystic fibrosis patients
Today (16 March 2023), Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) announces a £3 million Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF.
Catherine Kettleborough Beverley Isherwood Danielle Ellis Paula Sommer Collaborative Discovery Programme Cf Syndicate
Source: news-medical.net